PCSK9 and hyperlipidemia: Notably, several clinical studies have demonstrated the antiplatelet effects of PCSK9 in patients with hypercholesterolemia and found it to be an effective and safe strategy for treating patients with uncontrolled hyperlipidemia and coronary artery disease [65,66].